Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de David Pyott
Age : 67
Public asset : 12,850,854 USD
Country of residence : Unknown
Linked companies : Koninklijke Philips N.V. - Alnylam Pharmaceuticals, Inc. - BioMarin Pharmaceutical Inc. - Pliant Therapeutics, Inc.

Biography of David Pyott 
David E. I. Pyott is a British businessperson who has been at the head of 7 different companies. Presently, he occupies the position of Chairman of Bioniz Therapeutics, Inc., Chief Executive Officer & Director at Serica Technologies, Inc. and President of Vicept Therapeutics, Inc. Dr. Pyott is also President at International Council of Ophthalmology Foundation and on the board of 13 other companies. David E. I. Pyott previously was Head-Nutrition Division at Novartis AG and President & Chief Executive Officer for Sandoz Nutrition Corp. (a subsidiary of Novartis AG), Chairman & Chief Executive Officer at Allergan, Inc. and Chairman for California Healthcare Institute. He received a graduate degree from The University of Edinburgh and an MBA from London Business School.


Current positions of David Pyott 
Holdings of David Pyott 
David Pyott : Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/24CATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/24ELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/24BARRY DILLER : Stock Futures Weaken After Evergrande Payment Deadline Passes
DJ
More news


© 2021 People and Ownership :   
David Pyott : Connections 


Latest news about David Pyott 
01/12Pliant Therapeutics, Inc. Announces Appointment of David Pyott to Board of Directors
CI
2017Sienna Labs, Inc. announced that it has received $40.47 million in funding from a group of investors
CI
2015DAVID PYOTT : Actavis says Allergan's Pyott won't join new company's board
RE
2015How the Actavis deal upended Allergan No. 2's CEO ambitions
RE
2014Allergan agrees to $66 bln Actavis offer; Valeant walks
RE
2014Allergan agrees to $66 billion Actavis offer; Valeant walks
RE
2014Allergan says has been approached by another party about a deal
RE
More news